Common supplement tested to protect brains in progressive MS
NCT ID NCT05122559
Summary
This study is testing whether N-acetyl cysteine (NAC), an over-the-counter antioxidant supplement, can slow brain shrinkage in people with progressive multiple sclerosis. 98 participants aged 40-70 with progressive MS will receive either NAC or a placebo for 15 months. Researchers will use brain scans to measure if NAC protects against brain tissue loss and check if it improves walking, hand function, or thinking skills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.